| 000 | 01757 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514231822.0 | ||
| 264 | 0 | _c20050817 | |
| 008 | 200508s 0 0 pol d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCzerwieńska, Beata | |
| 245 | 0 | 0 |
_a[Effect of orlistat therapy on carbohydrate, lipid, vitamin and hormone plasma levels in obese subjects]. _h[electronic resource] |
| 260 |
_bPolskie Archiwum Medycyny Wewnetrznej _cDec 2004 |
||
| 300 |
_a1415-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Obesity Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aCarbohydrates _xblood |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHormones _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercholesterolemia _xdrug therapy |
| 650 | 0 | 4 |
_aHyperlipidemias _xdrug therapy |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 |
_aLactones _xadministration & dosage |
| 650 | 0 | 4 |
_aLeptin _xblood |
| 650 | 0 | 4 |
_aLipase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeuropeptide Y _xblood |
| 650 | 0 | 4 |
_aObesity _xblood |
| 650 | 0 | 4 | _aOrlistat |
| 650 | 0 | 4 | _aPoland |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 650 | 0 | 4 |
_aVitamins _xblood |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aKokot, Franciszek | |
| 700 | 1 | _aFranek, Edward | |
| 700 | 1 | _aIrzyniec, Tomasz | |
| 700 | 1 | _aWiecek, Andrzej | |
| 773 | 0 |
_tPolskie Archiwum Medycyny Wewnetrznej _gvol. 112 _gno. 6 _gp. 1415-23 |
|
| 999 |
_c15621121 _d15621121 |
||